Submitted by Anonymous (not verified) on 3 June 2026 - 15:22
Human medicines European public assessment report (EPAR): Namuscla, Mexiletine, Date of authorisation: 18/12/2018, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Namuscla, Mexiletine, Date of authorisation: 18/12/2018, Revision: 9, Status: Authorised